Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy

Diabetes - United States
doi 10.2337/db11-1072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Screening of Natural Compounds as Activators of the Keap1-Nrf2 Pathway

Planta Medica
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2013English

NRF2-targeted Therapeutics: New Targets and Modes of NRF2 Regulation

Current Opinion in Toxicology
Toxicology
2016English

Viper Venom for Diabetic Nephropathy

Kidney International
Nephrology
2012English

Autophagy as a Therapeutic Target in Diabetic Nephropathy

Experimental Diabetes Research
2012English

Drugs for Diabetic Nephropathy- Full Review

World Journal of Pharmacy and Pharmaceutical Sciences
2017English

Signal Transducers and Activators of Transcription: Novel Targets for Anticancer Therapeutics

Cancer Control
MedicineOncologyHematology
1999English

Role of Nrf2 and Its Activators in Respiratory Diseases

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy